Novel Trial for the Treatment of Steroid Dependency in Minimal Change Disease: Combined Therapy of Camostat Mesilate and Glycyrrhizin

[1]  Y. Taguma,et al.  Anti-proteinuric and anti-coagulatory effects of camostat mesilate in azotemic diabetics. , 1992, Nihon Jinzo Gakkai shi.

[2]  Y. Taguma,et al.  Effect of camostat mesilate on persistent proteinuria of IgA nephropathy. , 1992, Nephron.

[3]  F. Shimada,et al.  Effect of oral administration of glycyrrhizin on the pharmacokinetics of prednisolone. , 1991, Endocrinologia japonica.

[4]  H. Makino,et al.  Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy. , 1991, The Journal of diabetic complications.

[5]  Y. Taguma,et al.  Effect of camostat mesilate for the treatment of advanced diabetic nephropathy. , 1990, The Journal of laboratory and clinical medicine.

[6]  Y. Taguma,et al.  Effect of camostat mesilate on heavy proteinuria in various nephropathies. , 1989, Clinical nephrology.

[7]  M. Mihatsch,et al.  Risk factors for the development of chronic cyclosporine-nephrotoxicity. , 1988, Clinical nephrology.

[8]  W. Kaufmann,et al.  In vivo effects of camostat mesilate on plasma kallikrein, plasma kininase II and renal kallikrein of man. , 1987, Arzneimittel-Forschung.

[9]  P. Hoyer,et al.  CYCLOSPORIN IN FREQUENTLY RELAPSING MINIMAL CHANGE NEPHROTIC SYNDROME , 1986, The Lancet.

[10]  R. Kikkawa,et al.  Hypokalemia and sodium retention in patients with diabetes and chronic hepatitis receiving insulin and glycyrrhizin. , 1983, Endocrinologia japonica.

[11]  L. Wash,et al.  Licorice-induced pseudoaldosteronism. , 1975, American journal of hospital pharmacy.

[12]  M. Muramatu,et al.  Inhibitory effects of -amino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. , 1971, Biochimica et biophysica acta.

[13]  M. Muramatu,et al.  Inhibitory effects of -guanidino acid esters on trypsin, plasmin, plasma kallikrein and thrombin. , 1971, Biochimica et biophysica acta.